[시장보고서]미국의 당뇨병 모니터링, 치료, 약물전달 시장 : 시장 규모, 동향 분석(2025-2031년)

미국의 당뇨병 모니터링, 치료, 약물전달 시장 : 시장 규모, 동향 분석(2025-2031년) - MedSuite

Diabetes Monitoring, Treatment and Drug Delivery Market Size, Share & Trends Analysis | United States | 2025-2031 | MedSuite | Includes: Insulin & GLP-1, Continuous Glucose Monitoring and 7 more

상품코드 : 1663179

리서치사 : iData Research Inc.

발행일 : 2025년 02월

페이지 정보 : 영문 236 Pages

라이선스 & 가격 (부가세 별도)

US $ 7,995

￦ 11,345,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,995

￦ 12,764,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 9,995

￦ 14,183,000

PDF (Corporate License)

PDF 보고서를 동일 기업(해외)의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

미국의 당뇨병 모니터링·치료·약물전달 시장 규모는 2024년에 480억 달러에 달했습니다. 이 시장은 향후 7.3%의 CAGR로 확대하며, 2031년에는 790억 달러에 달할 것으로 예측됩니다.

2024년에 가장 빠르게 성장하는 부문은 인슐린 및 GLP-1 수용체 작용제 시장으로, 전체 시장 규모의 대부분을 차지할 것으로 예상됩니다.

복용량 추적, 인슐린 필요량 계산, 알림 제공 등의 기능으로 인해 스마트 인슐린 펜에 대한 수요가 증가하고 있습니다. 이러한 장비는 당뇨병 관리를 강화하고 높은 가격에도 불구하고 높은 편의성을 제공하며, CGM, 인슐린 전달 시스템, 디지털 건강 솔루션의 지속적인 개선으로 시장의 발전이 기대됩니다.

미국의 당뇨병 모니터링·치료·약물전달 시장에 대해 조사했으며, 시장의 개요와 부문별 동향, 시장 성장 촉진요인 및 억제요인, 경쟁 시장 점유율 분석 등을 제공하고 있습니다.

영문목차

The U.S. diabetes monitoring, treatment, and drug delivery market was valued at $48 billion in 2024 and is projected to grow at a CAGR of 7.3%, reaching $79 billion by 2031.

This report covers key market segments, including:

Blood Glucose Meters, Blood Glucose Test Strips, Lancets
Continuous Glucose Monitoring (CGM) & Flash Glucose Monitoring (FGM)
Insulin & GLP-1 Receptor Agonists (e.g., Ozempic(R))
Insulin Pens, Insulin Syringes, and Insulin Pumps

Key Market Segment Insights

The largest and fastest-growing segment in 2024 was the insulin and GLP-1 receptor agonist market, which accounted for the majority of total market value. The growth of GLP-1 therapies is driven by:

Rising prevalence of type 2 diabetes and obesity
Increased demand for innovative treatment solutions
Advancements in therapies that address both diabetes and obesity
Market Data Highlights

The report includes:

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Market Drivers & Limiters
Market Forecasts Until 2031 and Historical Data from 2021
Competitive Analysis & Market Shares
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
U.S. Diabetes Market Trends
Smart Reusable Insulin Pens: The demand for smart insulin pens is increasing due to their ability to track doses, calculate insulin requirements, and provide reminders. These devices enhance diabetes management and offer greater convenience despite higher pricing.
Technological Advancements: Continuous improvements in CGM, insulin delivery systems, and digital health solutions are expected to drive the market forward.

Market Share Insights

Top Competitors in the U.S. Diabetes Market (2024):

1 Novo Nordisk

* Market leader in insulin and second in insulin pens.

* Top position in ultra-long-acting & ultra-rapid-acting insulin.

* Only competitor in the rapid-acting insulin market.

* GLP-1 portfolio includes Ozempic(R), Rybelsus(R), and Xultophy(R).

2 Eli Lilly

* Second-largest competitor in the insulin market.

* Leader in premixed insulin, ultra-rapid-acting insulin, and human insulin.

* GLP-1 portfolio includes Trulicity(R), Mounjaro(R), and Zepbound(R).

3 Dexcom

* Dominates the continuous glucose monitoring (CGM) market.

* Strong sales from G6(R) (FDA approval in 2018) and G7 (FDA approval in 2023).

Market Segmentation Summary

This report suite includes all relevant market data, but individual MedCore reports are available for specific segments.

Blood Glucose Meter Market

Segmented Into: Personal & Professional

Blood Glucose Test Strip Market

Segmented Into: Personal & Professional

Lancet Market

Segmented Into: Personal & Professional

Continuous Glucose Monitoring (CGM) Market

Segmented Into: Personal & Professional

Flash Glucose Monitoring (FGM) Market

Segmented Into: Readers & Sensors

Insulin and GLP-1 Market

Insulin Types: Long-Acting, Ultra-Long-Acting, Rapid-Acting, Ultra-Rapid-Acting, Premixed, Human
GLP-1 Segments:

Diabetes Care: GLP-1 Injection, GLP-1 Oral

Obesity Care: GLP-1 Injection

Insulin Pen Market

Segmented Into: Reusable Pens & Pen Needles

Insulin Syringe Market

Segmented Into: Conventional & Safety Syringes

Insulin Pump Market

Segmented Into: Durable, Patch, and Simple Pumps

Global Research Scope

Report Attributes and Details:

Region: United States
Base Year: 2024
Forecast Period: 2025-2031
Historical Data: 2021-2023

Quantitative Coverage:

Market Size, Market Shares, Market Forecasts, Growth Rates
Units Sold, Average Selling Prices

Qualitative Coverage:

COVID-19 Impact
Market Trends & Limiters
Competitive Analysis & SWOT for Leading Competitors
Mergers & Acquisitions
Company Profiles & Product Portfolios
FDA Recalls & Disruptive Technologies
Disease Overviews

Data Sources:

Industry Leader Interviews
Government & Regulatory Data
Hospital & Private Sector Data
Import & Export Records
iData Research Internal Database

TABLE OF CONTENT

Table of Contents

List of Figures

List of Charts

Executive Summary

U.S. Diabetes Monitoring, Treatment and Drug Delivery Market Overview

Competitive Analysis

Emerging Markets and Technologies

Market Developments

Market Trends

Market Segmentation

Key Report Updates

Version History

research methodology

Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

Disease Overview

2.1 Introduction
- 2.1.1 Types of Diabetes
- 2.1.2 Diabetes Complications
- 2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
- 2.1.4 Signs and Symptoms
- 2.1.5 Diabetes Monitoring
- 2.1.6 Treatment
- 2.1.7 Drug Delivery Systems

U.S. Diabetes Monitoring, Treatment and Drug Delivery Market Overview

3.1 Introduction
3.2 Market Overview & Trend Analysis
3.3 Drivers and Limiters
- 3.3.1 Market Drivers
- 3.3.2 Market Limiters
3.4 Competitive Market Share Analysis
3.5 Mergers and Acquisitions

patient demographics AND INSTALLED BASE

4.1 Patient Demographics
- 4.1.1 Diagnosed Diabetes Patient Population by Type
- 4.1.2 Diagnosed Type 2 Diabetes Patient Population by Type
- 4.1.3 Diagnosed Insulin-Dependent Diabetes Patient Population by Type
4.2 Installed Base Analysis and Forecast
- 4.2.1 Personal Glucose Monitoring Installed Base by Segment
- 4.2.2 Personal CGM Installed Base by Patient Type
- 4.2.3 Insulin User Installed Base by Segment
- 4.2.4 Durable Pump Installed Base by Diabetes Type
- 4.2.5 Patch Pump Installed Base by Diabetes Type
- 4.2.6 MDI Installed Base by Segment
- 4.2.7 MDI Installed Base by Diabetes Type

Blood glucose meter Market

5.1 Introduction
5.2 Market Overview
5.3 Market Analysis and Forecast
- 5.3.1 Personal Blood Glucose Meter Market
- 5.3.2 Professional Blood Glucose Meter Market
5.4 Drivers and Limiters
- 5.4.1 Market Drivers
- 5.4.2 Market Limiters
5.5 Competitive Market Share Analysis

Blood Glucose test strip Market

6.1 Introduction
6.2 Market Overview
6.3 Market Analysis and Forecast
- 6.3.1 Total Blood Glucose Test Strip Market
- 6.3.2 Personal Blood Glucose Test Strip Market
  - 6.3.2.1 Medicare/Medicaid Personal Blood Glucose Test Strip Market
  - 6.3.2.2 Managed Care Personal Blood Glucose Test Strip Market
  - 6.3.2.3 Personal Cash Blood Glucose Test Strip Market
- 6.3.3 Professional Blood Glucose Test Strip Market
6.4 Drivers and Limiters
- 6.4.1 Market Drivers
- 6.4.2 Market Limiters
6.5 Competitive Market Share Analysis

Lancet Market

7.1 Introduction
7.2 Market Overview
7.3 Market Analysis and Forecast
- 7.3.1 Total Lancet Market
- 7.3.2 Personal Lancet Market
- 7.3.3 Professional Lancet Market
7.4 Drivers and Limiters
- 7.4.1 Market Drivers
- 7.4.2 Market Limiters
7.5 Competitive Market Share Analysis

Continuous Glucose MonitorinG Market

8.1 Introduction
8.2 Market Overview
8.3 Market Analysis and Forecast
- 8.3.1 Personal Continuous Glucose Monitoring Market
  - 8.3.1.1 Personal Continuous Glucose Monitoring Receiver Market
  - 8.3.1.2 Personal Continuous Glucose Monitoring Transmitter Market
  - 8.3.1.3 Personal Continuous Glucose Monitoring Sensor Market
- 8.3.2 Professional Continuous Glucose Monitoring Market
  - 8.3.2.1 Professional Continuous Glucose Monitoring System Market
  - 8.3.2.2 Professional Continuous Glucose Monitoring Transmitter Market
  - 8.3.2.3 Professional Continuous Glucose Monitoring Sensor Market
8.4 Drivers and Limiters
- 8.4.1 Market Drivers
- 8.4.2 Market Limiters
8.5 Competitive Market Share Analysis
- 8.5.1 Continuous Glucose Monitoring Market Installed Base Share

Flash Glucose monitoring Market

9.1 Introduction
9.2 Market Overview
9.3 Market Analysis and Forecast
- 9.3.1 Flash Glucose Monitoring Reader Market
- 9.3.2 Flash Glucose Monitoring Sensor Market
9.4 Drivers and Limiters
- 9.4.1 Market Drivers
- 9.4.2 Market Limiters
9.5 Competitive Market Share Analysis

Insulin and GLP-1 Market

10.1 Introduction
- 10.1.1 Insulin Types
  - 10.1.1.1 Rapid-Acting Insulin Analog
  - 10.1.1.2 Ultra-Rapid-Acting Insulin Analog
  - 10.1.1.3 Regular Human Insulin
  - 10.1.1.4 Intermediate-Acting Human Insulin
  - 10.1.1.5 Long-Acting Insulin Analog
  - 10.1.1.6 Ultra-Long-Acting Insulin Analog
  - 10.1.1.7 Premixed Insulin
10.2 Market Overview
10.3 Market Analysis and Forecast
- 10.3.1 Insulin Market
  - 10.3.1.1 Long-Acting Insulin Market
  - 10.3.1.2 Ultra-Long-Acting Insulin Market
  - 10.3.1.3 Rapid-Acting Insulin Market
  - 10.3.1.4 Ultra-Rapid-Acting Insulin Market
  - 10.3.1.5 Premixed Insulin Market
  - 10.3.1.6 Human Insulin Market
- 10.3.2 GLP-1 Market
  - 10.3.2.1 GLP-1 Diabetes Care Injection Market
  - 10.3.2.2 GLP-1 Diabetes Care Oral Market
  - 10.3.2.3 GLP-1 Obesity Care Injection Market
10.4 Drivers and Limiters
- 10.4.1 Market Drivers
- 10.4.2 Market Limiters
10.5 Competitive Market Share Analysis

Insulin pen Market

11.1 Introduction
11.2 Market Overview
11.3 Market Analysis and Forecast
- 11.3.1 Reusable Pen Market
  - 11.3.1.1 Standard Reusable Pen Market
  - 11.3.1.2 Smart Reusable Pen Market
- 11.3.2 Pen Needle Market
  - 11.3.2.1 Conventional Pen Needle Market
  - 11.3.2.2 Safety Pen Needle Market
11.4 Drivers and Limiters
- 11.4.1 Market Drivers
- 11.4.2 Market Limiters
11.5 Competitive Market Share Analysis

Insulin Syringe Market

12.1 Introduction
12.2 Market Overview
12.3 Market Analysis and Forecast
- 12.3.1 Total Insulin Syringe Market
- 12.3.2 Conventional Insulin Syringe Market
- 12.3.3 Safety Insulin Syringe Market
12.4 Drivers and Limiters
- 12.4.1 Market Drivers
- 12.4.2 Market Limiters
12.5 Competitive Market Share Analysis

Insulin pump Market

13.1 Introduction
- 13.1.1 Durable Insulin Pumps
- 13.1.2 Patch Insulin Pumps
- 13.1.3 Simple Insulin Pumps
13.2 Market Overview
13.3 Market Analysis and Forecast
- 13.3.1 Durable Insulin Pump Market
  - 13.3.1.1 Durable Pump Market
  - 13.3.1.2 Infusion Set Market
  - 13.3.1.3 Pump Reservoir Market
- 13.3.2 Patch Insulin Pump Market
  - 13.3.2.1 Patch Pump System Market
  - 13.3.2.2 Insulin Pod Market
- 13.3.3 Simple Insulin Pump Market
13.4 Drivers and Limiters
- 13.4.1 Market Drivers
- 13.4.2 Market Limiters
13.5 Competitive Market Share Analysis
- 13.5.1 Durable Insulin Pump Market
- 13.5.2 Insulin Pump Market Installed Base Share

Abbreviations

한글목차

목차

개요

조사 방법

질환의 개요

미국의 당뇨병 모니터링·치료·약물전달 시장 개요

환자 인구통계와 설치 수

혈당 측정기 시장

혈당 검사 스트립 시장

랜싯 시장

연속 혈당 측정 시장

플래시 혈당 모니터링 시장

인슐린 및 GLP-1 시장

인슐린 펜 시장

인슐린 주사기 시장

인슐린 펌프 시장

약어

영문목차

TABLE OF CONTENT